Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hormonal therapies are safe and effective for treating adult women's acne.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.